184 related articles for article (PubMed ID: 29381681)
1. Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.
McClurg UL; Nabbi A; Ricordel C; Korolchuk S; McCracken S; Heer R; Wilson L; Butler LM; Irving-Hooper BK; Pedeux R; Robson CN; Riabowol KT; Binda O
Br J Cancer; 2018 Mar; 118(5):713-726. PubMed ID: 29381681
[TBL] [Abstract][Full Text] [Related]
2. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818
[TBL] [Abstract][Full Text] [Related]
3. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
4. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
5. ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.
Melekhova A; Baniahmad A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685579
[TBL] [Abstract][Full Text] [Related]
6. ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal.
Nabbi A; Almami A; Thakur S; Suzuki K; Boland D; Bismar TA; Riabowol K
Eur J Cell Biol; 2015 May; 94(5):214-22. PubMed ID: 25819753
[TBL] [Abstract][Full Text] [Related]
7. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
8. Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis.
Gou WF; Sun HZ; Zhao S; Niu ZF; Mao XY; Takano Y; Zheng HC
Indian J Med Res; 2014 Apr; 139(4):561-7. PubMed ID: 24927342
[TBL] [Abstract][Full Text] [Related]
9. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
10. ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells.
Wang Y; Li G
J Biol Chem; 2006 Apr; 281(17):11887-93. PubMed ID: 16520380
[TBL] [Abstract][Full Text] [Related]
11. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
Doyon Y; Cayrou C; Ullah M; Landry AJ; Côté V; Selleck W; Lane WS; Tan S; Yang XJ; Côté J
Mol Cell; 2006 Jan; 21(1):51-64. PubMed ID: 16387653
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).
Li X; Zhang Q; Zhang M; Luo Y; Fu Y
Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514
[TBL] [Abstract][Full Text] [Related]
13. Newly identified tumor suppressor functions of ING proteins.
Heliez L; Ricordel C; Becuwe P; Pedeux R
Curr Opin Pharmacol; 2023 Feb; 68():102324. PubMed ID: 36521226
[TBL] [Abstract][Full Text] [Related]
14. Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
Yang C; Gao J; Yan N; Wu B; Ren Y; Li H; Liang J
Oncol Rep; 2017 Jan; 37(1):587-593. PubMed ID: 27840947
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of ING3 protein and histone H3 binding.
Ferreras-Gutiérrez M; Chaves-Arquero B; González-Magaña A; Merino N; Amusategui-Mateu I; Huecas S; Medrano FJ; Blanco FJ
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124724. PubMed ID: 37148949
[TBL] [Abstract][Full Text] [Related]
16. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract][Full Text] [Related]
17. The ING tumor suppressors in cellular senescence and chromatin.
Ludwig S; Klitzsch A; Baniahmad A
Cell Biosci; 2011 Jul; 1(1):25. PubMed ID: 21767350
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of ING3 is required to suppress melanoma cell migration, invasion and angiogenesis.
Zhou R; Rotte A; Li G; Chen X; Chen G; Bhandaru M
Biochem Biophys Res Commun; 2020 Jun; 527(2):418-424. PubMed ID: 32334834
[TBL] [Abstract][Full Text] [Related]
19. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
